Page 8 - Thyroid Disorder News Today

The atezolizumab-bevacizumab combination is the first to show efficacy in the adjuvant setting after HCC resection for patients at high risk for recurrence, but the overall survival benefit is unclear.

Trying to lose weight unsuccessfully? Apart from getting older, there are a few important reasons why you have not been able to shed kilos despite following a regimented daily routine. According to health experts, these can range from a variety of underlying ailments like PCOS, hypothyroid, insomnia, etc. Read on to know more about these. , Health News, Times Now

Over the past 30 years, survival of patients with de novo metastatic cancers shows divergent trends, with substantial gains against some cancers but limited or no progress against others.

Three of the comorbidities examined appeared to be causally associated with an increased risk of IPF.

Reducing parathyroid hormone levels surgically in people with primary hyperparathyroidism improved cognition scores but had no significant effect on sleep quality.

No well-designed trials have shown efficacy for vitamins and supplements such as biotin, vitamin D, amino acids, and chromium for treating brittle nail syndrome, according to Dr Shari Lipner.

Immune checkpoint inhibitors, increasingly used to treat a variety of cancers, can cause unpredictable immune-related adverse events including endocrinopathies.

Misty Selph found herself with a rare metastatic cancer and an insurance plan that covered virtually none of the specialized care she required, forcing tough choices and delaying her care.

A study from the US Department of Defense found cancer incidence was higher among military air and ground crew in comparison with the general population, but they were not more likely to die from cancer.

The results add to current understanding of the role of different biomarkers in treatment response, in this population, according to the lead study author.